Publications by authors named "David Rushmore"

Claim this Profile
A
A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in Lymphoma.
Nagarajan Pattabiraman, Cosimo Lobello, David Rushmore, Luca Mologni, Mariusz Wasik

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance spectroscopy-based detection of response to therapy targeting glutaminolysis in lymphoma.
Kavindra Nath, Pradeep K Gupta, Shengchun Wang, Alexander A Shestov, Neil Sen, David Rushmore

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis